These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8380524

  • 1. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis.
    Uhl GR, Kitayama S.
    Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524
    [No Abstract] [Full Text] [Related]

  • 2. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease.
    Morino H, Kawarai T, Izumi Y, Kazuta T, Oda M, Komure O, Udaka F, Kameyama M, Nakamura S, Kawakami H.
    Ann Neurol; 2000 Apr; 47(4):528-31. PubMed ID: 10762168
    [Abstract] [Full Text] [Related]

  • 3. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
    Mash DC, Sanchez-Ramos J, Weiner WJ.
    Adv Neurol; 1993 Apr; 60():133-9. PubMed ID: 8420130
    [No Abstract] [Full Text] [Related]

  • 4. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F, Vaugeois JM, Petit M.
    Encephale; 1995 Apr; 21(6):445-51. PubMed ID: 8674469
    [Abstract] [Full Text] [Related]

  • 5. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease.
    Uhl GR.
    Ann Neurol; 1998 May; 43(5):555-60. PubMed ID: 9585349
    [No Abstract] [Full Text] [Related]

  • 6. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
    Le Couteur DG, Leighton PW, McCann SJ, Pond Sm.
    Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
    [Abstract] [Full Text] [Related]

  • 7. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
    Pifl C, Giros B, Caron MG.
    Adv Neurol; 1996 Sep; 69():235-8. PubMed ID: 8615133
    [No Abstract] [Full Text] [Related]

  • 8. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter.
    Gonon F, Burie JB, Jaber M, Benoit-Marand M, Dumartin B, Bloch B.
    Prog Brain Res; 2000 Sep; 125():291-302. PubMed ID: 11098665
    [No Abstract] [Full Text] [Related]

  • 9. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
    Nishimura M, Kaji R, Ohta M, Mizuta I, Kuno S.
    Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nicotine consumption and Parkinson's disease--does the smoke clear up?
    Vieregge P, Heberlein I.
    Mov Disord; 1995 May; 10(3):359-60. PubMed ID: 7651462
    [No Abstract] [Full Text] [Related]

  • 12. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
    Paus S, Seeger G, Brecht HM, Köster J, El-Faddagh M, Nöthen MM, Klockgether T, Wüllner U.
    Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A, Wersinger C, Vernier P.
    FEBS Lett; 2004 May 07; 565(1-3):1-5. PubMed ID: 15135042
    [Abstract] [Full Text] [Related]

  • 15. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J, Bergmans P, Winogrodzka A, Speelman JD, Wolters EC.
    Synapse; 2001 Feb 07; 39(2):101-8. PubMed ID: 11180497
    [Abstract] [Full Text] [Related]

  • 16. The serotonin transporter in Alzheimer's and Parkinson's disease.
    Mössner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP.
    J Neural Transm Suppl; 2000 Feb 07; (60):345-50. PubMed ID: 11205152
    [Abstract] [Full Text] [Related]

  • 17. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.
    Uhl GR.
    Mov Disord; 2003 Oct 07; 18 Suppl 7():S71-80. PubMed ID: 14531049
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
    Mössner R, Henneberg A, Schmitt A, Syagailo YV, Grässle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP.
    Mol Psychiatry; 2001 May 07; 6(3):350-2. PubMed ID: 11326308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.